Exon-targeted U1 snRNA rescues splicing defects and ameliorates inherited optic neuropathy: A novel RNA-based treatment

Key Points

• The aim is to evaluate the efficacy of exon-targeted U1 snRNA in correcting splicing defects associated with inherited optic neuropathy.
• Utilized an RNA-based therapeutic approach targeting specific exons.
• Assessed the impact on splicing efficiency using molecular assays.
• Evaluated the physiological effects in relevant cellular models.
• Demonstrated significant improvement in splicing parameters associated with optic neuropathy.
• Showed a reduction in cellular markers of degeneration linked to optic nerve health.
• Indicated potential for enhanced visual function in treated models.